Scott Whitaker, president and CEO of AdvaMed, The Medtech Association®, today urged Congress to enact a research and development expensing tax provision critical to medtech innovation. The provision would delay…
Scott Whitaker, President and CEO of AdvaMed, The Medtech Association®, urged the White House to delay the sale and privatization of the Federal Helium Reserve until concerns about resulting supply…
AdvaMed® President and CEO Scott Whitaker released the following statement regarding the 14th Ministerial-level Trade Policy Forum held in New Delhi, India:
In a new op-ed in RealClear Health, AdvaMed® President and CEO Scott Whitaker called on the Biden Administration to ensure the medtech industry is considered as it implements policies to…
Today, diabetes was front and center during a Senate HELP Committee hearing, prompting AdvaMed® President and CEO Scott Whitaker to release the following statement on the ways life-saving medical technology…
Today, AdvaMedDx® submitted comments in response to the Food and Drug Administration’s Proposed Rule: Medical Devices; Laboratory Developed Tests. AdvaMedDx® is a division of AdvaMed® representing companies that develop in…
Today, AdvaMed® President and CEO Scott Whitaker released the following statement upon House passage of The Prematurity Research Expansion and Education for Mothers who deliver Infants Early (PREEMIE) Reauthorization Act:
AdvaMed, The Medtech Association®, announced the establishment of a new Medical Imaging Technology division focused on advocating on behalf of large and small companies for the essential role of medical imaging technology,…
AdvaMed, The Medtech Association®, announced that Peter J. Arduini, president and CEO of GE HealthCare, will become the Chair of the AdvaMed® Board of Directors.
Today, AdvaMed, The Medtech Association®, released the following statement from President and CEO Scott Whitaker on the recent actions to strengthen supply chains announced by President Biden as part of…